NSEStatement of deviation(s) or variation(s) under Reg. 3229 Oct 2026 · 29 Oct 2026, 08:41 pm
Statement of deviation(s) or variation(s) under Reg. 32
Ind-Swift Laboratories Limited · INDSWFTLAB
✦ AI SummaryResults
Ind-Swift Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 regarding the utilization of funds raised through the preferential issue of 70,00,000 Fully Convertible Warrants. The company confirms that there has been no deviation or variation in the utilization of funds.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ind-Swift Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Attachments (1)
📄pdf
Download →
INDSWFTLAB_29102026204140_sdd70L.pdf
View document text
Ref: ISLL:CH:2026 Date: 29th October, 2026
The President The Vice President,
Corporate Relationship Department Listing Compliance Department,
BSE Limited National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor
25th Floor, Dalal Street, Plot No. C/2, G-Block,
Mumbai 400 001 Bandra Kurla Complex, Bandra (E),
Mumbai 400 051
BSE Scrip Code: 532305 NSE Symbol: INDSWFTLAB
SUB: NIL STATEMENT ON DEVIATION OR VARIATION OF FUNDS RAISED THROUGH
PREFERENTIAL ISSUE OF 70,00,000 FULLY CONVERTIBLE WARRANTS
Dear Sir/Ma’am,
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, and other applicable provisions relating to the format of the Statement of Deviation or Variation
in the utilisation of proceeds of public issues, rights issues, preferential issues, Qualified Institutions
Placements (QIPs), etc., we hereby confirm that there has been no deviation or variation in the utilisation
of funds raised through the preferential issue of 70,00,000 (Seventy Lakh) Fully Convertible Warrants
allotted on 17th September, 2026.
Accordingly, a Nil Statement of Deviation, duly reviewed by the Audit Committee of the Company, for
the Quarter ended 30th September, 2026 is given in "Annexure A".
Kindly take the same on your records.
Thanking you,
For IND-SWIFT LABORATORIES LTD.
PARDEEP VERMA
VP-CORPORATE AFFAIRS &
COMPANY SECRETARY
Annexure A
Statement of Deviation/variation in utilization of funds under Regulation 32 of SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015
We hereby state that the preferential issue proceeds of the Company as utilized during the quarter ended
30.09.2026 for the objects of the issue are given hereunder and there was no deviation in utilization of funds from
those stated in the letter of offer.
Statement of Deviation or Variation in utilization of funds raised
Name of listed entity : Ind-Swift Laboratories Limited
Mode of Fund Raising : Preferential Issue of Convertible Warrants
Date of Raising Funds : 17.09.2026
Amount Raised : Rs. 34.30 Crores out of the total issue size of Rs. 137.20
Crores
Report filed for Quarter ended : 30.09.2026
Monitoring Agency : Applicable
Monitoring Agency Name : CARE Ratings Limited
Is there a Deviation / Variation in use of funds raised : No
If yes, whether the same is pursuant to change in terms of : NA
a contract or objects, which was approved by the
shareholders
If Yes, Date of shareholder Approval : NA
Explanation for the Deviation / Variation : NA
Comments of the Audit Committee after review : NA
Comments of the auditors, if any : NA
Objects for which funds have been raised and where there has been a deviation, in the following table:
Original Object Modifie Original Modified Utilization Funds Amount of Remarks if
d Allocation allocation, during Utilized as Deviation/Variat any
Object, (in if any the quarter at ion for the
if any Crores) 30.09.2026 quarter
(in crores) according to
applicable object
Expansion of Out of total
Business: receipt of
a. Expansion of NA 41.40 NIL 6.31 6.31 NIL funds, a sum of
Existing Rs. 15.60
Manufacturing Crores has
Facility and been utilized
Setting up of a towards the
new Warehouse objects of the
b. Research & NA 2.00 NIL 0.33 0.33 NIL issue.
Development
(R&D’)
c. Technology NA 1.50 NIL 0.00 0.00 NIL
Upgradation
d. Investment NA 5.00 NIL 4.85 4.85 NIL
in subsidiary
To meet the NA 53.00 NIL 3.99 3.99 NIL
Working Capital
Requirements of
the Company
General Corporate NA 34.30 NIL 0.11 0.11 NIL
Purpose
Total 34.30 15.60 15.60
Deviation or Variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund-raising document i.e. prospectus, letter of offer,
etc.